Structural Biology of Human H3K9 Methyltransferases
暂无分享,去创建一个
Valérie Campagna-Slater | Matthieu Schapira | Abdellah Allali-Hassani | Alexander N. Plotnikov | Cheryl H. Arrowsmith | Vladimir V. Lunin | Jinrong Min | Masoud Vedadi | J. Min | C. Arrowsmith | M. Schapira | Valérie Campagna-Slater | M. Vedadi | A. Plotnikov | A. Allali-Hassani | V. Lunin | Hong Wu | T. Antoshenko | L. Dombrovski | H. Zeng | Hong Wu | Hong Zeng | Ludmila Dombrovski | Tatiana Antoshenko | J. Min
[1] E. Selker,et al. Structure of the Neurospora SET Domain Protein DIM-5, a Histone H3 Lysine Methyltransferase , 2002, Cell.
[2] Jon R. Wilson,et al. SET domains and histone methylation. , 2003, Current opinion in structural biology.
[3] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[4] Andrew J. Bannister,et al. Unsafe SETs: histone lysine methyltransferases and cancer. , 2002, Trends in biochemical sciences.
[5] Brian C. Smith,et al. Chemical mechanisms of histone lysine and arginine modifications. , 2009, Biochimica et biophysica acta.
[6] Pierre-Olivier Angrand,et al. The control of histone lysine methylation in epigenetic regulation. , 2007, Biochimie.
[7] Albert Jeltsch,et al. Analysis of the substrate specificity of the Dim-5 histone lysine methyltransferase using peptide arrays. , 2008, Chemistry & biology.
[8] D. Moazed,et al. Heterochromatin and Epigenetic Control of Gene Expression , 2003, Science.
[9] Xiaodong Cheng,et al. Protein lysine methyltransferase G9a acts on non-histone targets. , 2008, Nature chemical biology.
[10] George M Sheldrick,et al. Substructure solution with SHELXD. , 2002, Acta crystallographica. Section D, Biological crystallography.
[11] J. Snyder,et al. Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294 , 2009, Nature Structural &Molecular Biology.
[12] E. Selker,et al. Structural basis for the product specificity of histone lysine methyltransferases. , 2003, Molecular cell.
[13] T. Kouzarides. Chromatin Modifications and Their Function , 2007, Cell.
[14] Xing Zhang,et al. The SET-domain protein superfamily: protein lysine methyltransferases , 2005, Genome Biology.
[15] V S Lamzin,et al. ARP/wARP and molecular replacement. , 2001, Acta crystallographica. Section D, Biological crystallography.
[16] B. Ren,et al. Role of the Histone H3 Lysine 4 Methyltransferase, SET7/9, in the Regulation of NF-κB-dependent Inflammatory Genes , 2008, Journal of Biological Chemistry.
[17] Geoff Kelly,et al. Specificity and mechanism of the histone methyltransferase Pr-Set7. , 2005, Genes & development.
[18] Xiaobo Xia,et al. H3K79 methylation profiles define murine and human MLL-AF4 leukemias. , 2008, Cancer cell.
[19] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.
[20] A. Ventura,et al. Down-regulation of Enhancer of Zeste-2 decreases growth of estrogen receptor negative invasive breast carcinoma and requires BRCA1 , 2008, Oncogene.
[21] Ming-Ming Zhou,et al. Structural insights of the specificity and catalysis of a viral histone H3 lysine 27 methyltransferase. , 2006, Journal of molecular biology.
[22] E. Selker,et al. In Vitro and in Vivo Analyses of a Phe/Tyr Switch Controlling Product Specificity of Histone Lysine Methyltransferases* , 2005, Journal of Biological Chemistry.
[23] Sheng Ding,et al. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. , 2008, Cell stem cell.
[24] Joseph S Brunzelle,et al. Structural and functional analysis of SET8, a histone H4 Lys-20 methyltransferase. , 2005, Genes & development.
[25] R. Trievel,et al. Structural origins for the product specificity of SET domain protein methyltransferases , 2008, Proceedings of the National Academy of Sciences.
[26] Stacie L. Bulfer,et al. A coupled fluorescent assay for histone methyltransferases. , 2005, Analytical biochemistry.
[27] Robert E Collins,et al. Structural and sequence motifs of protein (histone) methylation enzymes. , 2005, Annual review of biophysics and biomolecular structure.
[28] Andrew J. Bannister,et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain , 2001, Nature.
[29] Cyrus Martin,et al. The diverse functions of histone lysine methylation , 2005, Nature Reviews Molecular Cell Biology.
[30] C. Qian,et al. SET domain protein lysine methyltransferases: Structure, specificity and catalysis , 2006, Cellular and Molecular Life Sciences CMLS.
[31] Jon R. Wilson,et al. Structural basis for the requirement of additional factors for MLL1 SET domain activity and recognition of epigenetic marks. , 2009, Molecular cell.
[32] Z. Otwinowski,et al. research papers Acta Crystallographica Section A Foundations of , 2003 .
[33] R. Marmorstein. Structure of SET domain proteins: a new twist on histone methylation. , 2003, Trends in biochemical sciences.
[34] J. Martens,et al. Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. , 2003, Molecular cell.
[35] A Vagin,et al. An approach to multi-copy search in molecular replacement. , 2000, Acta crystallographica. Section D, Biological crystallography.
[36] Geoff Kelly,et al. Structure and catalytic mechanism of the human histone methyltransferase SET7/9 , 2003, Nature.
[37] Robert A. Copeland,et al. Protein methyltransferases as a target class for drug discovery , 2009, Nature Reviews Drug Discovery.
[38] The Emerging Therapeutic Potential of Histone Methyltransferase and Demethylase Inhibitors , 2009, ChemMedChem.
[39] Karl Mechtler,et al. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins , 2001, Nature.